| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |